Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Vertex

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vertex to Participate in Upcoming September Investor Conferences
    Vertex to Participate in Upcoming September Investor Conferences

    22 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240822736102/en

    BUSINESSWIRE
    22 Aug 2024
    Share Share
    Vertex Reports Second Quarter 2024 Financial Results
    Vertex Reports Second Quarter 2024 Financial Results

    01 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240801201006/en

    BUSINESSWIRE
    01 Aug 2024
    Share Share
    Vertex: TRIKAFTA® Benefit Data At Cystic Fibrosis Conference
    Vertex: TRIKAFTA® Benefit Data At Cystic Fibrosis Conference

    07 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240606593406/en

    BUSINESSWIRE
    07 Jun 2024
    Share Share
    Vertex touts Casgevy sickle cell launch as bluebird makes progress Lyfgenia
    Vertex touts Casgevy sickle cell launch as bluebird makes progress Lyfgenia

    06 May 2024

    // ENDPTS

    https://endpts.com/vertex-touts-casgevy-sickle-cell-launch-as-bluebird-makes-progress-with-rival-lyfgenia/

    ENDPTS
    06 May 2024
    Share Share
    Vertex Advances Inaxaplin into Ph 3 for the Treatment of APOL1-Mediated KD
    Vertex Advances Inaxaplin into Ph 3 for the Treatment of APOL1-Mediated KD

    01 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240401112879/en

    BUSINESSWIRE
    01 Apr 2024
    Share Share
    Lonza, Vertex Break Ground for Cell Therapy Mfg. Facility
    Lonza, Vertex Break Ground for Cell Therapy Mfg. Facility

    31 Aug 2023

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2023-08-31/lonza-vertex-break-ground-for-cell-therapy-mfg-facility/

    CONTRACT PHARMA
    31 Aug 2023
    Share Share